0001114220-18-000039.txt : 20180420 0001114220-18-000039.hdr.sgml : 20180420 20180420161125 ACCESSION NUMBER: 0001114220-18-000039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180418 FILED AS OF DATE: 20180420 DATE AS OF CHANGE: 20180420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carberry Christine A. CENTRAL INDEX KEY: 0001694459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 18766794 MAIL ADDRESS: STREET 1: ONE MARINA PARK DRIVE, 12TH FLOOR STREET 2: C/O KERYX BIOPHARMACEUTICALS, INC. CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-466-3500 MAIL ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 4 1 wf-form4_152425503801315.xml FORM 4 X0306 4 2018-04-18 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001694459 Carberry Christine A. C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 0 1 0 0 Chief Operating Officer Common Stock 2018-04-18 4 S 0 2026 4.83 D 115176 D Sale of a total of 2,026 shares of common stock was made in order to satisfy Ms. Carberry's income tax withholding obligation upon the vesting of 7,084 shares of restricted stock on April 17, 2018. Ms. Carberry had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock. Includes 90,832 shares of restricted stock. /s/ Scott A. Holmes, Attorney-in-Fact 2018-04-20